Related Experiment Videos
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy
S A Factor1, J R Sanchez-Ramos, W J Weiner
1University of Miami School of Medicine, Department of Neurology, Florida 33101.
Journal of Neurology, Neurosurgery, and Psychiatry
|April 1, 1988
Abstract:
Sixty-three patients with Parkinson's disease who failed bromocriptine therapy for various reasons were treated in an open-label trial of pergolide. The data were evaluated in a retrospective manner. Forty-six percent had a good response and tolerated the pergolide. A comparison of the outcomes regarding response and toxicity revealed that bromocriptine and pergolide act differently in individual patients. A trial of pergolide in Parkinsonian patients failing bromocriptine therapy may be therapeutically useful.